When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?

Cleve Clin J Med. 2024 Jan 2;91(1):47-51. doi: 10.3949/ccjm.91a.23034.

¹ Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.
² Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH.
³ Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH; Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH.
⁴ Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH; Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH tangw@ccf.org.

No abstract available

MeSH terms